A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.
Topical Agenda for April 24 Briefing:
IDSA will discuss its COVID-19 antibody testing primer, released on Tuesday (4/21).
What are the opportunities and challenges presented by antibody tests?
What is the current state of the many different antibody tests offered, and data they reveal?
Can antibody tests predict immunity?
Despite limitations, should antibody tests still be widely used?
Questions from media
FEATURING:
Mary K. Hayden, MD, FIDSA — Chicago, IL
Spokesperson, Infectious Diseases Society of America
Professor of Internal Medicine and Pathology
Chief, Division of Infectious Diseases & Director, Division of Clinical Microbiology
Rush University Medical Center
Liise-anne Pirofski, MD, FIDSA — New York, NY
Spokesperson, Infectious Diseases Society of America
Mitrani Professor of Biomedical Research
Chief, Division of Infectious Diseases
Albert Einstein College of Medicine and Montefiore Medical Center
Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America
